Relmada Therapeutics, Inc.
RLMDNASDAQNASDAQ Global Select·USD·Closed
$3.55
−$0.36 (9.21%)
$3.55
−$0.36 (9.21%)
Not investment advice.Learn more
The signals we see for RLMD lean cautious.
We couldn't find analysis data for RLMD. Please try again later.
Continue with finqOS
SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.
14-day free trial · No credit card required
52W Range
Mid-range
Volume
Market Cap
Small-cap company
P/E Ratio
Div Yield
No dividend